Reference number : 172-2018-2019-Q3-916584, amendment number : , agreement type : C, recipient legal name : 9493662 CANADA Inc, recipient country : CA, recipient province : QC, recipient city : Montreal|Montréal, recipient postal code : H4R 3E9, program name english : Industrial Research Assistance Program – Contributions to Firms, program name french : Programme d’aide à la recherche industrielle – Contributions aux entreprises, program purpose english : The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization, program purpose french : Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation, agreement title english : High throughput screening platform to accelerate development of drugs targeting neurological diseases, agreement title french : Plate-forme de dépistage à haut débit pour accélérer le développement de médicaments ciblant les maladies neurologiques, agreement number : 916584, agreement value : 81000.0, agreement start date : 2018-11-05, agreement end date : 2019-08-02, description english : Ananda Devices' proprietary Neuro-microfluidic device (MFD) offers a more efficient model to test drugs targeting neurological diseases in vitro. The Neuro-MFD enables up to 90% cost reduction with reagents and samples and up to 50% faster data analysis in cultures of humans-derived neurons. However, each Neuro-MFD can only test one drug per experiment. To sell to the biopharmaceutical industry market, here we propose to adapt the Neuro-MFD to the industry standard high throughput screening (HTS) plate format, enabling testing of thousands of drugs/experimental conditions., description french : Plate-forme de dépistage à haut débit pour accélérer le développement de médicaments ciblant les maladies neurologiques, expected results english : The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization, expected results french : Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation, additional information english : nan, additional information french : nan, owner organization : nrc-cnrc, owner organization title : National Research Council Canada | Conseil national de recherches Canada